Search Results - "van Dorst, E.B.L."

Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program by Beerman, H, van Dorst, E.B.L, Kuenen-Boumeester, V, Hogendoorn, P.C.W

“…Abstract Objective Liquid-based cytology may offer improvements over conventional cytology for cervical cancer screening. The two cytology techniques were…”
Get full text

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours by Nagtegaal, S.H.J., Hulsbergen, A.F.C., van Dorst, E.B.L., Kavouridis, V.K., Jessurun, C.A.C., Broekman, M.L.D., Smith, T.R., Verhoeff, J.J.C.

“…•The largest cohort of brain metastases patients from gynaecological tumours.•CA-125, age and primary tumour type are prognostic for survival.•This will inform…”
Get full text

Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy by Klerkx, W.M, Heintz, A.P.M, Mali, W.P.ThM, de Kort, G.A.P, Takahara, T, van Dorst, E.B.L, Peeters, P.H.M

“…Abstract Objective Pelvic lymphadenectomy is considered the gold standard to diagnose and possibly treat lymphatic metastases in gynaecological cancer…”
Get full text

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective by Bokkers, K., Frederix, G.W.J., Velthuizen, M.E., van der Aa, M., Gerestein, C.G., van Dorst, E.B.L., Lange, J.G., Louwers, J.A., Koole, W., Zweemer, R.P., Ausems, M.G.E.M.

“…OBJECTIVEGermline genetic testing is increasingly offered to patients with epithelial ovarian cancer by non-genetic healthcare professionals, so called…”
Get full text

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe by Van der Kolk, W.L., Van der Zee, A.G.J., Slomovitz, B.M., Baldwin, P.J.W., Van Doorn, H.C., De Hullu, J.A., Van der Velden, J., Gaarenstroom, K.N., Slangen, B.F.M., Kjolhede, P., Brännström, M., Vergote, I., Holland, C.M., Coleman, R., Van Dorst, E.B.L., Van Driel, W.J., Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P.A., Mannel, R.S., Tjiong, M.Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Monk, B.J., Zanagnolo, V., Tamussino, K., Oonk, M.H.M., Levenback, C.F., Hermans, R.H., Bouda, J., Sharma, A., Luesley, D., Ellis, P., Cruickshank, D.J., Duncan, T.J., Kieser, K., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M., Dhar, K., Asher, V., Tobias, D.H., Borgfeldt, C., Lea, J.S., Lood, M., Bailey, J., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Persson, P., Manchanda, R., Jensen, P., Van Le, L.

“…OBJECTIVEOptimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal…”
Get full text

Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit by Algera, M.D., van Driel, W.J., Slangen, B.F.M., Wouters, M.W.J.M., Kruitwagen, R.F.P.M., Kruse, A.J., Yigit, R., Engelen, M.J.A., Nooij, L.S., Mens, J.W.M., de Jong, M.A.A., Haverkort, M.A.D., van der Aa, M., Diepstraten, J., van Ham, M.A.P.C., Smedts, H.P.M., Reesink, N., Gaarenstroom, K.N., Vencken, P.M.L.H., Boll, D., Fons, G., Baalbergen, A., van Dorst, E.B.L., Roes, E.M., Nagel, H.T.C., van Ginkel, A., de Waard, J., Hofman, L.N.

“…Despite lacking clinical data, the Dutch government is considering increasing the minimum annual surgical volume per center from twenty to fifty cytoreductive…”
Get full text

Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA) by Baldewpersad Tewarie, N.M.S., van Driel, W.J., van Ham, M., Wouters, M.W., Kruitwagen, R., Kruse, A.J., Yigit, R., van der Aa, M., Mens, J.W., Stam, T.C., Diepstraten, J., van der Kolk, A., Verhoeve, H., Smedts, H.P.M., van Haaften-de Jong, A.M.L.D., Reesink, N., Vos, M.C., Ten Cate, A.D., Slangen, B.F.M., Timmers, P.J., Smit, R.A., Gaarenstroom, K.N., Vencken, P.M.L.H., Engelen, M.J.A., Verbruggen, M.B., Boll, D., Briet, J., Fons, G., Coppus, S.F.P.J., Baalbergen, A., van Dorst, E.B.L., Tjiong, M.Y., Roes, E.M., Visschers, B.A.J.T., Gerestein, C.G., Nagel, H.T.C., Aalders, A.L., Hofman, L., Lange, J., Ebisch, I., de Waard, J., van der Plas-Koning, Y.W.C.M., Huisman, M.

“…The challenge when performing cytoreductive surgery (CRS) is to balance the benefits and risks. The aim of this study was to report short term postoperative…”
Get full text

The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model by Damstra, Robert J., Halk, Anne-Berth, Damstra, R.J., Halk, B., van den Berg, J.P., Born, Y., Butter, E.S.F.A., van Dorst, E.B.L., van Everdingen, J.J.E., Feenstra, C., Gielink, P., de Haas, M.J., van der Heide-Schoon, G., Hendrickx, A., Hidding, J.T., Storm van Leeuwen, J.B., Nijland, S., Oskam, E., Paulusma, I., Russell, N., Rutgers-van Wijlen, K., Sissingh, I., Strobbe, L.J.A., Verhoeff- Braat, C.J.A., Verwaard, R., van der Vleuten, C., Voesten, H.G.J.M., Hartog, A., Urgert, M.C.

“…Lymphedema is a chronic and progressive condition due to an imbalance between lymphatic filtration and transport capacity. A relative overload of fluid is…”
Get full text